New Micro-Laparoscopic Instruments Offer Surgeons Less Invasive Option for Patients

FRANKLIN LAKES, N.J., JUNE 20, 2017 - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its new line of Snowden-Pencer 3.0mm laparoscopic ergonomic take-apart instruments received U.S. Food and Drug Administration (FDA) 510(k) clearance for use in laparoscopic surgery.

The new line of Snowden-Pencer 3.0mm laparoscopic ergonomic take-apart instruments are designed for micro-laparoscopic surgery and function like 5.0mm instruments. The jaw lengths of the devices mirror those of standard laparoscopic instruments, providing surgeons with a less invasive approach without compromising instrument functionality.

The launch of this new line enables BD to offer one of the most customizable portfolios of 3.0mm micro-laparoscopic instruments available. It offers 26 different jaw patterns, 2 different lengths (24cm, 36cm) and 6-take-apart handles, resulting in 312 combinations to target procedures in multiple specialties. The micro-laparoscopic devices are also compatible with an interchangeable modular system that includes the standard Snowden-Pencer 5.0mm and 10.0mm laparoscopic instruments.

The new Snowden-Pencer micro-laparoscopic instrument is used in procedures known to provide patients with a virtually scar-less procedure, reduce post-operative pain, improve post-operative appearance and reduce hospital stays.

'Minimally invasive micro-laparoscopic surgery is a steadily growing field resulting from patient demand for less invasive surgical options and scar reduction,' said Jim Leitl, worldwide vice president and general manager of Infection Prevention, V. Mueller and Interventional Specialties for BD. 'This innovative new line of instruments enables providers to choose the best surgical option for their patients.'

The new line of micro-laparoscopic devices is the latest in BD's line of take-apart surgical instruments that are designed for easy assembly and disassembly to support sterility initiatives and are engineered to withstand demanding sterile processing techniques. For more information visit: http://www.carefusion.com/our-products/surgical-instruments/

BD - Becton, Dickinson and Company published this content on 20 June 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 20 June 2017 19:10:15 UTC.

Original documenthttp://www.bd.com/en-us/company/news-and-media/press-releases/june-20-2017-bd-receives-fda-510k-clearance-for-new-line-of-customizable-30mm-micro-laparoscopic-instruments

Public permalinkhttp://www.publicnow.com/view/2B29FF3B814EE398B70AEA64FBA8907A61C666D2